The 2930A>G polymorphism of the CYBA gene is associated with premature coronary artery disease. A case-control study and gene-risk factors interactions

Molecular Biology Reports

Volumn 41, Issue 5, 2014, Pages 3287-3294

  Niemiec, Pawel ^a   Nowak, Tomasz ^a   Iwanicki, Tomasz ^a   Krauze, Jolanta ^a   Gorczynska Kosiorz, Sylwia ^a   Grzeszczak, Wladyslaw ^a   Ochalska Tyka, Anna ^b   Zak, Iwona ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b Regional Centre of Blood Donation and Blood Treatment in Raciborz   (Poland)

Author keywords

Atherosclerosis; CAD; CYBA; NADPH oxidase; Polymorphism

Indexed keywords

CYBA PROTEIN, HUMAN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ADULT; ALLELE; CASE CONTROL STUDY; CORONARY ARTERY DISEASE; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HUMAN; MALE; METABOLISM; MIDDLE AGED; PHENOTYPE; RISK; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ALLELES; CASE-CONTROL STUDIES; CORONARY ARTERY DISEASE; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NADPH OXIDASE; ODDS RATIO; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84905706326     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-014-3191-9     Document Type: Article

References (32)

1. Lassègue B, San Martín A, Griendling KK (2012) Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system. Circ Res 110:1364-1390
2. Nowak T, Niemiec P, Zak I (2013) The p22phox protein and the CYBA gene Their function and associations with atherosclerosis-related diseases in Polish. Wiad Lek 66:10-17
3. San José G, Fortuño A, Beloqui O, Díez J, Zalba G (2008) NADPH oxidase CYBA polymorphisms, oxidative stress and cardiovascular diseases. Clin Sci (Lond) 114:173-182 (Pubitemid 351293993)
4. Moreno MU, San José G, Orbe J, Páramo JA, Beloqui O, Díez J, Zalba G (2003) Preliminary characterisation of the promoter of the human p22(phox) gene: identification of a new polymorphism associated with hypertension. FEBS Lett 542:27-31 (Pubitemid 36555708)
5. San José G, Moreno MU, Oliván S, Beloqui O, Fortuño A, Díez J, Zalba G (2004) Functional effect of the p22phox -930A/G polymorphism on p22phox expression and NADPH oxidase activity in hypertension. Hypertension 44:163-169 (Pubitemid 39014233)
6. Moreno MU, San José G, Fortuño A, Beloqui O, Díez J, Zalba G (2006) The C242T CYBA polymorphism of NADPH oxidase is associated with essential hypertension. J Hypertens 24:1299-1306 (Pubitemid 43948329)
7. Wyche KE, Wang SS, Griendling KK, Dikalov SI, Austin H, Rao S, Fink B, Harrison DG, Zafari AM (2004) C242T CYBA polymorphism of the NADPH oxidase is associated with reduced respiratory burst in human neutrophils. Hypertension 43:1246-1251 (Pubitemid 38696914)
8. Mehranpour P, Wang SS, Blanco RR, Li W, Song Q, Lassègue B, Dikalov SI, Austin H, Zafari AM (2009) The C242T CYBA polymorphism as a major determinant of NADPH oxidase activity in patients with cardiovascular disease. Cardiovasc Hematol Agents Med Chem 7:251-259
9. Schirmer M, Hoffmann M, Kaya E, Tzvetkov M, Brockmöller J (2008) Genetic polymorphisms of NAD(P)H oxidase: variation in subunit expression and enzyme activity. Pharmacogenomics J 8:297-304 (Pubitemid 352038308)
10. Kokubo Y, Iwai N, Tago N, Inamoto N, Okayama A, Yamawaki H, Naraba H, Tomoike H (2005) Association analysis between hypertension and CYBA, CLCNKB, and KCNMB1 functional polymorphisms in the Japanese population - the suita study. Circ J 69:138-142 (Pubitemid 40313030)
11. Niemiec P, Zak I, Wita K (2007) The 242T variant of the CYBA gene polymorphism increases the risk of coronary artery disease associated with cigarette smoking and hypercholesterolemia. Coron Artery Dis 18:339-346 (Pubitemid 47186833)
12. Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-502
13. Rothman KJ (1974) Synergy and antagonism in cause-effect relationship. Am J Epidemiol 99:385-388
14. Lundberg M, Fredlund P, Hallqvist J, Diderichsen F (1996) A SAS program calculating three measures of interaction with confidence intervals. Epidemiology 7:655-656
15. Goliasch G, Wiesbauer F, Grafl A, Ponweiser E, Blessberger H, Tentzeris I, Wojta J, Schillinger M, Huber K, Maurer G, Mannhalter C, Sunder-Plassmann R (2011) The effect of p22-PHOX (CYBA) polymorphisms on premature coronary artery disease (≤40 years of age). Thromb Haemost 105:529-534
16. Xaplanteris P, Vlachopoulos C, Baou K, Vassiliadou C, Dima I, Ioakeimidis N, Stefanadis C (2010) The effect of p22(phox) -930A/G, A640G and C242T polymorphisms of NADPH oxidase on peripheral and central pressures in healthy, normotensive individuals. Hypertens Res 33:814-818
17. Fortuño A, Bidegain J, Baltanás A, Moreno MU, Montero L, Landecho MF, Beloqui O, Díez J, Zalba G (2010) Is leptin involved in phagocytic NADPH oxidase overactivity in obesity? Potential clinical implications. J Hypertens 28:1944-1950
18. Jiang F, Lim HK, Morris MJ, Prior L, Velkoska E, Wu X, Dusting GJ (2011) Systemic upregulation of NADPH oxidase in diet-induced obesity in rats. Redox Rep 16:223-229
19. Du J, Fan LM, Mai A, Li JM (2013) Crucial roles of Nox2-derived oxidative stress in deteriorating insulin receptor and endothelial function in dietary obesity of mice after middle age. Br J Pharmacol. doi:10.1111/bph.12336
20. Sarna LK, Wu N, Wang P, Hwang SY, Siow YL, O K (2012) Folic acid supplementation attenuates high fat diet induced hepatic oxidative stress via regulation of NADPH oxidase. Can J Physiol Pharmacol 90:155-165
21. Sukumar P, Viswambharan H, Imrie H, Cubbon RM, Yuldasheva N, Gage M, Galloway S, Skromna A, Kandavelu P, Santos CX, Gatenby VK, Smith J, Beech DJ, Wheatcroft SB, Channon KM, Shah AM, Kearney MT (2013) Nox2 NADPH oxidase has a critical role in insulin resistance-related endothelial cell dysfunction. Diabetes 62:2130-2134
22. Ochoa MC, Razquin C, Zalba G, Martínez-González MA, Martínez JA, Marti A (2008) G allele of the -930A>G polymorphism of the CYBA gene is associated with insulin resistance in obese subjects. J Physiol Biochem 64:127-133
23. Orosz Z, Csiszar A, Labinskyy N, Smith K, Kaminski PM, Ferdinandy P, Wolin MS, Rivera A, Ungvari Z (2007) Cigarette smoke-induced proinflammatory alterations in the endothelial phenotype: role of NAD(P)H oxidase activation. Am J Physiol Heart Circ Physiol 292:H130-H139 (Pubitemid 46105172)
24. Cheng SE, Lee IT, Lin CC, Kou YR, Yang CM (2010) Cigarette smoke particle-phase extract induces HO-1 expression in human tracheal smooth muscle cells: role of the c-Src/NADPH oxidase/MAPK/Nrf2 signaling pathway. Free Radic Biol Med 48:1410-1422
25. Jaimes EA, DeMaster EG, Tian RX, Raij L (2004) Stable compounds of cigarette smoke induce endothelial superoxide anion production via NADPH oxidase activation. Arterioscler Thromb Vasc Biol 24:1031-1036 (Pubitemid 38737827)
26. Rafacho BP, Azevedo PS, Polegato BF, Fernandes AA, Bertoline MA, Fernandes DC, Chiuso-Minicucci F, Roscani MG, Dos Santos PP, Matsubara LS, Matsubara BB, Laurindo FR, Paiva SA, Zornoff LA, Minicucci MF (2011) Tobacco smoke induces ventricular remodeling associated with an increase in NADPH oxidase activity. Cell Physiol Biochem 27:305-312
27. Fan M, Raitakari OT, Kähönen M, Juonala M, Hutri- Kähönen N, Pörsti I, Viikari J, Lehtimäki T (2009) The association between cigarette smoking and carotid intima-media thickness is influenced by the -930A/G CYBA gene polymorphism: the cardiovascular risk in young Finns study. Am J Hypertens 22:281-287
28. Niemiec P, Nowak T, Balcerzyk A, Krauze J, Zak I (2011) The CYBA gene A640G polymorphism influences predispositions to coronary artery disease through interactions with cigarette smoking and hypercholesterolemia. Biomarkers 16:405-412
29. Letonja MS, Nikolajević-Starčević J, Batista DC, Osredkar J, Petrovič D (2012) Association of the C242T polymorphism in the NADPH oxidase p22 phox gene with carotid atherosclerosis in Slovenian patients with type 2 diabetes. Mol Biol Rep 39:10121-10130
30. Wu Z, Lou Y, Jin W, Liu Y, Lu L, Chen Q, Xie Y, Lu G (2013) Relationship of the p22phox (CYBA) gene polymorphism C242T with risk of coronary artery disease: a meta-analysis. PLoS One. doi:10.1371/journal.pone.0070885
31. Jachymczyk T, Gryglewska B, Jachymczyk A, Grodzicki T (2003) Relation between the amount of donated blood and blood pressure in blood donors (in Polish). Arter hypertens 7:173-179
32. Kawecka-Jaszcz K, Posnik-Urbanska A, Jankowski P (2007) Prevalence of arterial hypertension in Poland - impact of gender (in Polish). Arter hypertens 5:377-383